Director Market Access Europe
CSL Behring
Radovan Tomic
CSL Behring - Director Market Access Europe
Radovan Tomic is the Director of Market Access for Europe in CSL Behring, focusing on haematology therapy area with the focus on real-word evidence and Health Economics as well as Health Technology Assessments in Haemophilia space. Prior to this role, Radovan was the HTA and reimbursement lead (GLP1 Diabetes) for the Europe Region at Novo Nordisk, Copenhagen, Denmark. He holds a master’s degree in Pharmacy and is a Master in both International Health Care Management Economics and Policy (MIHMEP) and Pharmaceutical Digital Marketing. He has ten years of experience within Market Access, Pricing & Reimbursement and HEOR for major pharmaceutical manufacturers throughout Europe, previously working for companies such as Sanofi Italia, Roche Italia, and Novartis. He has full lifecycle and strategic leadership experience, along with people and project management expertise in international markets. Radovan has authored a variety of publications across multiple disease areas, including haemophilia, diabetes, cardiovascular disease, virology, and rheumatology.
Sunday, July 10, 2022
6:30 PM – 7:30 PM
Sunday, July 10, 2022
6:30 PM – 7:30 PM